Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 14Multiple Myeloma 12Pain, Postoperative 10Neoplasms 9Agnosia 8Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Cancer Pain 5Breast Neoplasms 5Neoplasm Metastasis 4Lymphoma 4Leukemia 4Hodgkin Disease 4Head and Neck Neoplasms 4Burkitt Lymphoma 4Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Lymphoma, B-Cell 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Hairy Cell 3Hematologic Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Trigger Finger Disorder 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Mantle-Cell 2

Interventions

fludarabine phosphate 6Whole-Body Irradiation 5Therapeutics 5Mycophenolic Acid 5Cyclosporine 5Psychiatric Rehabilitation 4Peripheral Blood Stem Cell Transplantation 4midostaurin 3avapritinib 2Sunitinib 2Pentetic Acid 2Methotrexate 2Early Intervention, Educational 2Darbepoetin alfa 2Busulfan 2thymoglobulin 1ripretinib 1liposomal doxorubicin 1ibrutinib 1hydrocortisone valerate 1fludarabine 1ferrous sulfate 1ferric gluconate 1ethanolamine oleate 1denileukin diftitox 1Valganciclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thiotepa 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Mast-Cell × Acetaminophen × Clear all
NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Stanford University

Phase 2 Completed
36 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡